<h1>Sudeep Pharma Ltd to Host Earnings Call on August 5, 2026, Discuss Q1FY27 Performance</h1>
Nuvama Wealth Management is hosting a conference call for Sudeep Pharma Limited management to review the company's operational and financial performance for the quarter ended on June 30, 2026. The earnings call is scheduled for Wednesday, August 5, 2026, at 11:00 AM IST.
The meeting will feature representation from Sudeep Pharma Ltd, including Mr. Sujit Bhayani (Managing Director), Mr. Shanil Bhayani (Director), and Mr. Ketan Vyas (Chief Financial Officer). The conference call is being led by Mr. Archit Joshi of Nuvama Wealth Management.
A detailed breakdown of the earnings conference call time and access methods is provided below:
| Detail | Information |
|---|---|
| Date & Time | Wednesday, August 5, 2026 at 11:00 AM IST |
| Hosted By | Nuvama Wealth Management |
| Participants Representing Sudeep Pharma Ltd. | Mr. Sujit Bhayani (Managing Director), Mr. Shanil Bhayani (Director), and Mr. Ketan Vyas (Chief Financial Officer) |
The conference call provides international participants with multiple access options, including dial-in numbers for India, USA, UK, Singapore, and Hong Kong.
| Region | Access Type | Details |
|---|---|---|
| India | Primary Access Number | +91 22 6280 1123 / +91 22 7115 8024 |
| USA | Toll-Free No. | 1 866 746 2133 |
| UK | Toll-Free No. | 0 808 101 1573 |
| Singapore | Toll Free No. | 800 101 2045 |
| Hong Kong | Toll Free No. | 800 964 448 |
SUDEEPPHRM Stock Price Movement
As of 12:23 PM, shares of Sudeep Pharma Limited are trending up to ₹848.85, gaining 2.87% or ₹23.70 in the live market. The stock is currently seeing significant interest with a volume reaching 216,402 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.